Geode Capital Management LLC Raises Position in LENSAR, Inc. (NASDAQ:LNSR)

Geode Capital Management LLC raised its holdings in shares of LENSAR, Inc. (NASDAQ:LNSRFree Report) by 3.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 100,431 shares of the company’s stock after buying an additional 3,423 shares during the period. Geode Capital Management LLC owned about 0.86% of LENSAR worth $460,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of LNSR. Sanctuary Advisors LLC bought a new position in LENSAR during the 2nd quarter worth approximately $93,000. DCF Advisers LLC boosted its stake in shares of LENSAR by 1.4% during the second quarter. DCF Advisers LLC now owns 241,484 shares of the company’s stock valued at $1,087,000 after purchasing an additional 3,250 shares during the period. Finally, Brandes Investment Partners LP grew its holdings in shares of LENSAR by 12.8% in the second quarter. Brandes Investment Partners LP now owns 373,198 shares of the company’s stock worth $1,644,000 after purchasing an additional 42,250 shares during the last quarter. 40.15% of the stock is owned by institutional investors.

LENSAR Stock Down 1.2 %

Shares of NASDAQ LNSR opened at $8.25 on Monday. The firm’s fifty day moving average is $7.70 and its 200 day moving average is $5.80. LENSAR, Inc. has a 52 week low of $2.67 and a 52 week high of $9.23. The company has a market cap of $95.82 million, a price-to-earnings ratio of -5.65 and a beta of 0.63.

LENSAR Profile

(Free Report)

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

Read More

Want to see what other hedge funds are holding LNSR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LENSAR, Inc. (NASDAQ:LNSRFree Report).

Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.